Stock DZ
10.07.2018 kl 19:44


in the article I shared earlier "The value of secrecy for big pharma", you can read at the end the following (i am highlighting some key words):

"Indeed, companies which focus on developing a few blockbuster drugs for a select number of indications would clearly benefit from patent protection, WHEREAS companies looking to develop diagnostics, PERSONALISED THERAPEUTIC REGIMES and the like could also benefit from ‘BLACK BOX’ models, in which aspects of the invention are KEPT SECRET."

By "Personalised therapeutics regimes" they include CRISPR and RNAi. you can now link this directly to FimaNac research collaboration with the top 10 BP

Redigert 10.07.2018 kl 19:47 Arkivert